Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,38116,400 of 20,252 grants

Active NON SBIR/STTR CONTRACTS
TASK ORDER 75N91021F00001 FOR SUPPORT SERVICES FOR DEVELOPING AND PROMOTING METHODS AND STANDARDS FOR CANCER REGISTRY OPERATIONS AND SURVEILLANCE DATA
NATIONAL CANCER INSTITUTE North American Assn/Central Cancer Reg United States 2021 – 2026

The objective of this contract is to provide support to the North American Association of Central Cancer Registries (NAACCR) in order to make the National Cancer Institute?s (NCI)...

$11.5M
USD
Completed TRAINING, INDIVIDUAL
Dissecting the Execution Phase of BAK-Mediated Apoptosis in Cancer
NATIONAL CANCER INSTITUTE Harvard Medical School United States 2021 – 2024

PROJECT SUMMARY BCL-2 family proteins are critical regulators of apoptosis and deregulation of their protein interactions contributes to the development and chemoresistance of canc...

$379.8K
USD
Completed TRAINING, INDIVIDUAL
Elucidating transcriptomic and functional heterogeneity of microglia in low-grade glioma and glioma-associated epilepsy.
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Low-grade glioma (LGG) is a disease that, despite the modern standard of care, frequently recurs or progresses to high- grade glioma, such as glioblastoma...

$517.5K
USD
Completed TRAINING, INDIVIDUAL
Understanding the role of TWIST1 in colorectal cancer progression and metastasis
NATIONAL CANCER INSTITUTE Harvard Medical School United States 2021 – 2024

Project Summary: Although almost all colorectal cancer (CRC) mortality is due to metastasis, there are currently no drugs to prevent or halt metastasis. A better understanding of t...

$517.5K
USD
Completed NON-SBIR/STTR RPGS
Rational design of drug combinations to target chemotherapy resistance in high-grade serous ovarian cancer via metabolomic profiling of patient-derived organoids
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2021 – 2024

Project Summary/Abstract This resistant disease rates women, metabolomics resistance, of algorithm To regulatory of organoids. identified therapies project aims to develop a novel,...

$847.5K
USD
Completed NON-SBIR/STTR RPGS
Optimizing NK Cell-Engaging Bispecific Antibody Therapy Targeting CD33
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2021 – 2024

ABSTRACT CD33-targeted therapies have long been pursued in acute myeloid leukemia (AML). Longer survival of some patients treated with the antibody-drug conjugate gemtuzumab ozogam...

$2.02M
USD
Completed NON-SBIR/STTR RPGS
Dose-Rate Variations for Patient Treatments in Flash and conventional radiation therapy
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2024

Radiation therapy has been an important component in the treatment of cancer for many decades. While the parameters of tumor control have been relatively well understood, normal ti...

$1.92M
USD
Completed NON-SBIR/STTR RPGS
The regulation of mutant p53 protein accumulation in cancer: molecular basis and therapeutic potential
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2023

Abstract Tumor suppressor p53 is the most frequently mutated gene in human cancer, including colorectal cancer (CRC). Many tumor-associated mutant p53 (mutp53) proteins not only lo...

$4.1M
USD
Completed OTHER RESEARCH-RELATED
Characterizing Chromatin Remodeling Mechanisms of Chemo-Sensitivity and Resistance in Pediatric Solid Tumors
NATIONAL CANCER INSTITUTE Boston Children'S Hospital United States 2021 – 2025

PROJECT SUMMARY Despite the known roles of chromatin remodeling complexes in driving more than 20% of human cancer, the role of chromatin remodeling complexes in conferring therape...

$969.6K
USD
Completed NON-SBIR/STTR RPGS
Development of an Integrated mHealth App-Based Intervention to Support Smoking Cessation in People Living with HIV
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2025

PROJECT SUMMARY / ABSTRACT The advent of highly active antiretroviral therapy (HAART) has greatly reduced mortality in persons living with HIV (PLWH), to the point where now lifest...

$2.1M
USD
Active NON-SBIR/STTR RPGS
Improving pediatric brain tumor treatments using FLASH radiotherapy
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2026

PROJECT SUMMARY Our R01 application entitled, “Improving pediatric brain tumor treatments using FLASH radiotherapy” is focused on translating a novel irradiation modality into clin...

$5.03M
USD
Completed OTHER RESEARCH-RELATED
Characterizing Chromatin Remodeling Mechanisms of Chemo-Sensitivity and Resistance in Pediatric Solid Tumors
NATIONAL CANCER INSTITUTE Boston Children'S Hospital United States 2021 – 2025

PROJECT SUMMARY Despite the known roles of chromatin remodeling complexes in driving more than 20% of human cancer, the role of chromatin remodeling complexes in conferring therape...

$955.4K
USD
Completed RESEARCH CENTERS
University of Colorado Cancer Center Support Grant
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2022

Abstract The UCCC is the only NCI-designated Cancer Center in Colorado and has as its catchment area the entire State of Colorado.There are conceptually two ?Colorados?: the Front...

$1.15M
USD
Completed RESEARCH CENTERS
Abramson Cancer Center Support Grant
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2023

PROJECT SUMMARY ?Abramson Cancer Center The Abramson Cancer Center (ACC) at the University of Pennsylvania is one of the oldest NCI-Designated Comprehensive Cancer Centers.The ACC...

$1.15M
USD
Completed NON-SBIR/STTR RPGS
Implementation and Evaluation of an Expanded Bilingual Electronic Symptom Management Program across a Multi-site, Fully-integrated Comprehensive Cancer Center
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2023

Project Summary Physical and functional symptom burden is high among cancer survivors and is an ideal target for chronic care management.Cancer-related physical and functional side...

$4.28M
USD
Completed NON-SBIR/STTR RPGS
SCH: ChangeGradients: Promoting Health Behavior Change with Clinically Integrated Sample-Efficient Policy Gradient Methods
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2023

Because the majority of adolescent health problems are amenable to behavioral intervention and most adolescents visit a healthcare provider once a year, hea lth behavior change int...

$1.08M
USD
Completed NON-SBIR/STTR RPGS
Harnessing the Power of p53 with Panaxynol from American Ginseng to Suppress Colitis and Prevent Colon Cancer - admin supp
NATIONAL CANCER INSTITUTE University of South Carolina At Columbia United States 2021 – 2024

PROJECT SUMMARY Inflammatory Bowel Disease (IBD) is a chronic condition with a high risk for development of colon cancer. This illness has a high financial burden due to its relaps...

$265.4K
USD
Completed NON-SBIR/STTR RPGS
Polarizing Macrophages to Tumor Suppressors by Blocking Multiple CCR2 Chemokine Receptor Epitopes
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2024

Project Summary Despite the important role of the tumor stroma in cancer progression, the vast majority of anticancer therapies target cancer cells and not the tumor microenvironme...

$506.5K
USD
Completed NON-SBIR/STTR RPGS
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2023

Project Summary Chronic inflammatory conditions such as aging and obesity harmonize with cancer cell mutations to trigger and promote tumor development and progression. Hence, just...

$1.05M
USD
Completed NON-SBIR/STTR RPGS
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2023

Project Summary MICA and MICB (MICA/B) are stress proteins that are frequently expressed by diverse types of human cancer as a consequence of genomic damage, but are rarely express...

$1.26M
USD